ONL Therapeutics
Michal Silverberg - Director
Adam Cotton - Observer
Ophthalmology
Ann Arbor, MI USA
ONL Therapeutics is a clinical-stage biopharmaceutical company developing first-in-class therapeutics to protect and improve the vision of patients with retinal disease.